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Abstract
Intensive monitoring and aggressive management of perioperative
haemodynamics (goal directed therapy) have repeatedly been
reported to reduce the significant morbidity and mortality
associated with high risk surgery. It may not matter what particular
monitor is used to assess cardiac output but it is essential to
ensure adequate oxygen delivery. If this management cannot begin
preoperatively, it is still worth beginning goal directed therapy in
the immediate postoperative period.
Haemodynamic monitoring and manipulation are cornerstones
of critical care management. In this issue of Critical Care,
Pearse et al. report two interesting related studies in this area,
examining the effectiveness of postoperative goal directed
therapy following major surgery [1] and the use of central
venous saturation (ScvO2) monitoring in these patients [2].
As the authors at St George’s Hospital, London, point out,
despite their own work [3] and that of others [4,5]
demonstrating the benefit of preoperative goal directed therapy
(GDT) for high risk surgery patients, GDT has not become
routine practice. One can speculate why this might be. A lack
of intensive care beds to allow preoperative admission may be
responsible for not instituting GDT; however, a study from
York, UK, found that preoperative GDT did not increase overall
intensive care use [5]. GDT is a bundle of care that includes
intensive care unit (ICU) monitoring, fluids, blood transfusion
and inotropes, and it is difficult to know if the benefits of GDT
are due to all or just some of these components. Of note for
practitioners, the safety of the pulmonary artery (PA) catheter
has been questioned [6] and this was a core technology to
measure cardiac output in earlier GDT studies.
Pearse and colleagues have taken the pragmatic view that if
the intensive care community will not take up preoperative
GDT, then perhaps postoperative GDT is more palatable, and
so they studied the efficacy of the latter. They demonstrated
that even when only applied postoperatively for the first eight
hours, GDT (as defined by their protocol) significantly
reduced complication rates and hospital length of stay [1].
The two groups received similar volumes of crystalloid and
blood but the GDT group received on average an extra 700
ml of colloid and, as dictated by the protocol, more patients in
the GDT group achieved the oxygen delivery goal of
600 ml min–1 m–2. Mortality rates were similar in both groups.
This was a well conducted randomised controlled study that
importantly had an appropriately managed control group. It is,
however, subject to some limitations. Although it is difficult to
blind GDT interventions, attempts were made to blind
treatment allocation from the clinical team. Fluid management
could have been subject to intentional or unintentional bias,
however, because decisions about fluid treatment were made
by the unblinded research team. Although there were
predefined protocols for fluid administration, these protocols
did include subjective criteria: “clinical suspicion of persistent
hypovolaemia”. This potential source of bias could be
important because the treatment group has consistently
received more fluid in prior studies and this may well be the
major contributor to success of GDT.
The significant reduction of complications and hospital stay
should be sufficient to convince most clinicians, patients and
hospital administrators of the benefits of GDT. The study was
powered to detect a reduction in complication rates from
50% to 34%. This goal was met at the first interim analysis
and so the study was appropriately terminated with only 122
patients recruited. It is, therefore, difficult to interpret mortality
data in such an under-powered sample size. The
interpretation of mortality rates is also confounded by the
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higher predicted mortality from the P-POSSUM score in the
GDT group than the control group.
As the use of PA catheters has decreased in clinical practice
[7], it is important to assess whether alternative indicators of
inadequate cardiac output are good markers in GDT. In the
first paper [1], cardiac output was not determined using PA
catheters but by lithium indicator dilution and pulse contour
analysis. The second paper by Pearse et al. [2] pursues the
issue of alternative indicators of an adequate oxygen delivery
further. They report that a low ScvO2 was associated with an
increased complication rate [2]. Further studies are required
to determine whether ScvO2 can be used as an alternative
to the PA catheter to direct GDT in high risk surgical
patients.
A couple of other findings in this second study are worth
noting. The authors found that ScvO2 and cardiac index were
both independently associated with complication rates but
that GDT was not. As they point out, this suggests that
ensuring an adequate oxygen delivery is achieved is more
important than the specific protocol of GDT. It is another
explanation for the clinical equipoise about the use of GDT in
high risk surgical patients.
Pearse and colleagues [2] also found that ScvO2 levels
dropped quite markedly in the first hour postoperatively
without changes in other parameters such as blood pressure,
heart rate, base deficit or lactate measurement. This finding
and the correlation of ScvO2 with complications illustrate
why it may be important that these high risk patients receive
GDT for some time before transfer to the general ward. This
has important resource implications, especially in the UK
where this study was conducted, as historically there has
been a relative lack of both intensive care and high
dependency beds [8,9].
Taken together, these two studies [1,2] and previous studies
of preoperative optimization [3-5] show that it is possible to
reduce the high morbidity and mortality of high risk surgery
[10]. It may not matter what particular blood flow monitoring
method is used [1,4,11] as long as an adequate oxygen
delivery is achieved. It makes sense that this aggressive
resuscitation with fluid and inotropes, if necessary, occurs as
soon as possible in the operating theatre [11], if not pre-
operatively, and that it should continue into the postoperative
period. Even if it has not occurred pre- or intra-operatively,
however, these and other studies suggest that GDT is still
worth starting immediately postoperatively [1,2,12,13].
Premature transfer of patients to general wards misses the
GDT opportunity and may be harmful based on studies
showing that patients who require ICU admission from the
general ward postoperatively have a very poor prognosis
[14]. Studies in sepsis of goal directed therapy show
substantial efficacy when started early [15] but not once
organ failure is established [16].
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